{"id":781963,"date":"2023-09-06T07:15:20","date_gmt":"2023-09-06T11:15:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/"},"modified":"2023-09-06T07:15:20","modified_gmt":"2023-09-06T11:15:20","slug":"bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/","title":{"rendered":"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting<\/b><\/p>\n<p class=\"bwalignc\"><i><b>Company-Sponsored Educational Events Will Feature Latest Surgical Technologies, Including the SeeLuma\u2122 Fully Digital Surgical Visualization Platform, MIMS<sup>\u00ae<\/sup> and the IC-8<sup>\u00ae<\/sup> Apthera IOL<\/b><\/i><\/p>\n<p>VAUGHAN, Ontario&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nBausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced 13 podium and poster presentations during the European Society of Cataract and Refractive Surgery (ESCRS) <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.escrs.org%2F&amp;esheet=53549289&amp;newsitemid=20230906824036&amp;lan=en-US&amp;anchor=annual+meeting&amp;index=1&amp;md5=ade19a0c5ae0ed29750da3b9c365f564\">annual meeting<\/a>, which will take place in Vienna Sept. 8-12, 2023.<\/p>\n<p>\nThe presentations will include:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nA three-year analysis of the superonasal minimally invasive micro sclerostomy (MIMS) surgical treatment for open angle glaucoma*<\/p>\n<\/li>\n<li>\nInterim results of surgical procedures that used MINT\u2122 (Minimally Invasive Nasal Trabeculostomy) in open angle glaucoma patients<\/p>\n<\/li>\n<li>\nAn evaluation of visual outcomes in patients with complex corneas who were implanted with the IC-8 Apthera intraocular lens (IOL)<\/p>\n<\/li>\n<li>\nClinical outcomes of the LuxSmart\u2122 toric IOL<\/p>\n<\/li>\n<li>\nSafety and performance results of the enVista<sup>\u00ae<\/sup> ENVY, an investigational premium IOL<\/p>\n<\/li>\n<li>\nRefractive outcomes of a low 0.90 diameter cylinder for the investigational enVista Toric IOL.<\/p>\n<\/li>\n<\/ul>\n<p>\nBausch + Lomb will also host several educational and networking events during the meeting. Educational events will include a MIMS masterclass and a panel of distinguished physicians who will provide insights from their firsthand clinical experience using the company\u2019s <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bausch.com%2Fnews%2F%3Fid%3D145&amp;esheet=53549289&amp;newsitemid=20230906824036&amp;lan=en-US&amp;anchor=newly+launched&amp;index=2&amp;md5=0a67692f0d4024db03052d17a900e9f9\">newly launched<\/a> SeeLuma Fully Digital Surgical Visualization Platform. Other presentations featuring the company\u2019s latest surgical technology will take place in the Bausch + Lomb booth, and Bausch + Lomb will host a Lift Off Celebration event to mark its 170<sup>th<\/sup> anniversary.<\/p>\n<p>\nFollowing is the list of key scientific podium and e-poster presentations, as well as details for the featured educational events:<\/p>\n<p><b>Podium Presentations<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>\u201cEvaluating the Range of Vision with a Small Aperture IOL in Patients Previously Treated with a Monofocal IOL in the Other Eye.\u201d<\/i> S. Bafna et al.\n<\/li>\n<li><i>\u201cEvaluation of the Safety and Performance of a Novel One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens: Results from a Prospective, Multicentre Clinical Trial.\u201d <\/i>P. Harasymowycz et al.\n<\/li>\n<li><i>\u201cEvaluation of Visual Outcomes in Patients with Complex Corneas Implanted with the IC-8 IOL.\u201d<\/i> J. Mehta et al.\n<\/li>\n<li><i>\u201cProspective Study of Small Aperture IOL Implantation in Eyes with Previous Refractive Procedures.\u201d<\/i> R.E. Ang et al.\n<\/li>\n<\/ul>\n<p><b>Poster Presentations<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n\u201c<i>Clinical Outcomes After Bilateral Implantation of The Enhanced Depth of Focus LuxSmart Intraocular Lenses<\/i>.\u201d W. Lubi\u0144ski et al<\/p>\n<\/li>\n<li><i>\u201cClinical Outcomes of a Toric Extended Range of Vision Intraocular Lens Based on the Combination of Fourth- and Sixth-Order Spherical.\u201d<\/i> R. Ruiz-Mesa et al.\n<\/li>\n<li><i>\u201cComparison of Two Extended Range of Focus Intraocular Lenses: Vivity Vs. Luxsmart.\u201d<\/i> J. Hugues et al.\n<\/li>\n<li><i>\u201cRetinal Visualization in a Small Aperture IOL Treated Eyes.\u201d<\/i> M. Blecher et al.\n<\/li>\n<li><i>\u201cVisual Performance of Ultra-Low Cylinder Powered (0,90) Toric IOL Compared to Non-Toric.\u201d<\/i> A. Muzychuk et al.\n<\/li>\n<li><i>\u201cMinimally Invasive Micro Sclerostomy: 3 Years Follow Ups.\u201d<\/i> L. Voskanyan et al.\n<\/li>\n<li><i>\u201cTrabeculostomy as a New Effective Surgery for Glaucoma.\u201d<\/i> L. Voskanyan et al.\n<\/li>\n<li>\n\u201c<i>Acufocus IC-8 Implantation During Cataract Surgery in Irregular Corneas<\/i>.\u201d C. Hubert et al<\/p>\n<\/li>\n<li>\n\u201c<i>Visual Outcomes Following Implantation of Small Aperture Intraocular Lens in Patients with Irregular Corneas<\/i>.\u201d U. Bhatt<\/p>\n<\/li>\n<\/ul>\n<p><b>Featured Educational Events<br \/>\n<br \/><\/b><span class=\"bwuline\">Friday, September 8<\/span><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n\u201cMIMS Masterclass\u201d<br \/>\n<br \/>5:30-7:30 p.m. CEST at Palais Palffy, Josefsplatz 6, Vienna<br \/>\n<br \/><i>Professor<\/i><i> Anselm J\u00fcnemann, Dr. Imran Masood, Professor Luis Pablo and Dr. Lilit Voskanyan will present their experiences with the MIMS surgical treatment for open angle glaucoma.<\/i><\/li>\n<\/ul>\n<p><span class=\"bwuline\">Saturday, September 9<\/span><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n\u201cNew Dimensions in Visualization: Changing the Way You Look &amp; Your Patients See\u201d<br \/>\n<br \/>1:00-2:00 p.m. CEST at Messe Wien Exhibition &amp; Congress Centre, Room A7, Vienna<br \/>\n<br \/><i>Professor Burkhard Dick will lead an engaging conversation with an international panel of surgeons, including Drs. Robert Ang, Alain Saad and Adam Muzychuk, who will share their surgical experiences using the IC-8 Apthera IOL, SeeLuma Fully Digital Visualization Platform and Stellaris Elite\u2122 Phacoemulsification System, respectively.<\/i><\/li>\n<\/ul>\n<p><span class=\"bwuline\">Saturday, September 9 and Sunday, September 10<\/span><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n&#8220;Meet the Expert\u201d<br \/>\n<br \/>9:30 a.m.-4:30 p.m. CEST at Messe Wien Exhibition &amp; Congress Centre, booth #B203, Vienna<br \/>\n<br \/><i>Surgeons will share their surgical experiences using the LuxSmart\u2122 IOL, IC-8 Apthera IOL, SeeLuma Fully Digital Visualization Platform, Stellaris Elite and the refractive SUPRACOR\u2122 and transepi PRK procedures.<\/i><\/li>\n<\/ul>\n<p><span class=\"bwuline\">Sunday, September 10<\/span><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n\u201cLift Off Celebration\u201d<br \/>\n<br \/>6:30-10:30 p.m. CEST at Palais Ferstel, Strauchgasse 4, Vienna<br \/>\n<br \/><i>ESCRS attendees are invited to celebrate Bausch + Lomb\u2019s 170<sup>th<\/sup> anniversary.<\/i><\/li>\n<\/ul>\n<p>\nFor more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.bauschsurgical.eu%2Fescrs%2F&amp;esheet=53549289&amp;newsitemid=20230906824036&amp;lan=en-US&amp;anchor=https%3A%2F%2Fevents.bauschsurgical.eu%2Fescrs%2F&amp;index=3&amp;md5=cce7460027540760e42d9cecdd5d318a\">https:\/\/events.bauschsurgical.eu\/escrs\/<\/a>.<\/p>\n<p><b>About Bausch + Lomb<br \/>\n<br \/><\/b>Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world \u2013 from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bausch.com%2F&amp;esheet=53549289&amp;newsitemid=20230906824036&amp;lan=en-US&amp;anchor=www.bausch.com&amp;index=4&amp;md5=7b09d2a77e95a411bb37d9209ddba440\">www.bausch.com<\/a> and connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FBauschLomb&amp;esheet=53549289&amp;newsitemid=20230906824036&amp;lan=en-US&amp;anchor=Twitter&amp;index=5&amp;md5=c823f4b01b41a206031ed6193280cad6\">Twitter<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbausch-%26-lomb&amp;esheet=53549289&amp;newsitemid=20230906824036&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=82488e5834b32819933c6991c9469bb8\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FBauschandLomb&amp;esheet=53549289&amp;newsitemid=20230906824036&amp;lan=en-US&amp;anchor=Facebook&amp;index=7&amp;md5=2cc29e1011b799156eb46f3e470ed48c\">Facebook<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fbauschlomb%2F%3Fhl%3Den&amp;esheet=53549289&amp;newsitemid=20230906824036&amp;lan=en-US&amp;anchor=Instagram&amp;index=8&amp;md5=df078a699a0960ff950247cad3744cf9\">Instagram<\/a>.<\/p>\n<p><b>Forward-looking Statements<br \/>\n<br \/><\/b>This news release may contain forward-looking statements, which may generally be identified by the use of the words \u201canticipates,\u201d \u201chopes,\u201d \u201cexpects,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cmay,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cpotential,\u201d \u201ctarget,\u201d or \u201ccontinue\u201d and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb\u2019s filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.<\/p>\n<p><i>*Bausch + Lomb exclusively distributes MIMS in Europe through a strategic agreement with Sanoculis.<\/i><\/p>\n<p><i>\u00a9 2023 Bausch + Lomb.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230906824036\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230906824036\/en\/<\/a><\/span><\/p>\n<p><b>Media Contacts:<br \/>\n<\/b><br \/>Lainie Keller<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:lainie.keller@bausch.com\">lainie.keller@bausch.com<br \/>\n<\/a><br \/>(908) 927-1198<\/p>\n<p>\nKristy Marks<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Kristy.marks@bausch.com\">Kristy.marks@bausch.com<br \/>\n<\/a><br \/>(908) 927-0683<\/p>\n<p><b>Investor Contacts:<br \/>\n<\/b><br \/>George Gadkowski<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:george.gadkowski@bausch.com\">george.gadkowski@bausch.com<br \/>\n<\/a><br \/>(877) 354-3705 (toll free)<br \/>\n<br \/>(908) 927-0735<\/p>\n<p><b>KEYWORDS:<\/b> Austria Europe North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Surgery General Health Research Science Pharmaceutical Optical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230906824036\/en\/1668940\/3\/Bausch_%2B_Lomb_logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting Company-Sponsored Educational Events Will Feature Latest Surgical Technologies, Including the SeeLuma\u2122 Fully Digital Surgical Visualization Platform, MIMS\u00ae and the IC-8\u00ae Apthera IOL VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced 13 podium and poster presentations during the European Society of Cataract and Refractive Surgery (ESCRS) annual meeting, which will take place in Vienna Sept. 8-12, 2023. The presentations will include: A three-year analysis of the superonasal minimally invasive micro sclerostomy (MIMS) surgical treatment for open angle glaucoma* Interim &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781963","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting Company-Sponsored Educational Events Will Feature Latest Surgical Technologies, Including the SeeLuma\u2122 Fully Digital Surgical Visualization Platform, MIMS\u00ae and the IC-8\u00ae Apthera IOL VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced 13 podium and poster presentations during the European Society of Cataract and Refractive Surgery (ESCRS) annual meeting, which will take place in Vienna Sept. 8-12, 2023. The presentations will include: A three-year analysis of the superonasal minimally invasive micro sclerostomy (MIMS) surgical treatment for open angle glaucoma* Interim &hellip; Continue reading &quot;Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-06T11:15:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting\",\"datePublished\":\"2023-09-06T11:15:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\"},\"wordCount\":1102,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\",\"name\":\"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-09-06T11:15:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting - Market Newsdesk","og_description":"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting Company-Sponsored Educational Events Will Feature Latest Surgical Technologies, Including the SeeLuma\u2122 Fully Digital Surgical Visualization Platform, MIMS\u00ae and the IC-8\u00ae Apthera IOL VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced 13 podium and poster presentations during the European Society of Cataract and Refractive Surgery (ESCRS) annual meeting, which will take place in Vienna Sept. 8-12, 2023. The presentations will include: A three-year analysis of the superonasal minimally invasive micro sclerostomy (MIMS) surgical treatment for open angle glaucoma* Interim &hellip; Continue reading \"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-06T11:15:20+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting","datePublished":"2023-09-06T11:15:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/"},"wordCount":1102,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/","name":"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-09-06T11:15:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230906824036r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-european-society-of-cataract-and-refractive-surgery-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781963"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781963\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}